Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03397654
Title Study of Pembrolizumab Following TACE in Primary Liver Carcinoma (PETAL)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Imperial College London
Age Groups: adult | senior
Covered Countries GBR

No variant requirements are available.